ArticleJournal of audiology & otology2022
Expansion to the Motion Sickness Susceptibility Questionnaire-Short Form: A Cross-Sectional Study.
Article in Journal of audiology & otology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Evaluating fluid-filled glasses for motion sickness symptom mitigation in a computer-assisted rehabilitation environment (CAREN).Journal of neuroengineering and rehabilitation · 2026Trial
- Frequency-Dependent Reduction of Cybersickness in Virtual Reality by Transcranial Oscillatory Stimulation of the Vestibular Cortex.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023Trial
- Functional and imaging anomalies of the vestibular system in motion sickness: a clinical observation study.BMC medical imaging · 2025Observational
- Effects of within-day intervals on adaptation to visually induced motion sickness in a virtual-reality motorcycling simulator.Scientific reports · 2024Article
- Relationship Between Motion Sickness Susceptibility and Vestibular Test Results.Medeniyet medical journal · 2024Article
- Investigation of the Correlation Between the Visually Induced Motion Sickness Susceptibility Questionnaire and the Turkish Motion Sickness Susceptibility Questionnaire.Journal of audiology & otology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesThe primary objective of this study is to investigate the necessity of questioning virtual reality systems in the motion sickness susceptibility questionnaire (MSSQ)-short form. The secondary objective of this study is to determine the validity and reliability of the Turkish version of the MSSQ-short form, with proven validity and reliability. SUBJECTS AND
methodsIn the questionnaire form, for which expert opinion was obtained to maintain linguistic equivalence, the virtual reality items were added to the questionnaire. The questionnaire was then administered to 297 individuals. The results were statistically analyzed with and without these virtual reality items for validity and reliability.
resultsAfter the addition of the virtual reality items, the reliability of the questionnaire was found to be quite high (Cronbach's alpha r=0.912). The norm values between the original MSSQ-short form (12.9±9.9) and the Turkish MSSQ-short form (13.8±12.9) were found to be consistent.
conclusionsMotion sickness symptoms can occur not only during movement, but also with indirect stimulus. Our findings suggest that adding virtual reality items to the original form is important in long term practical applications. Our results show that the Turkish version of the original questionnaire is quite reliable. Submission of the MSSQ-short form in Turkish will be useful for documentation and will also encourage further research in this area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.